Strickler, J. H., Kawazoe, A., Li, J., Shen, L., Fang, H., Aristide, M. R. N., Vasilopoulos, A., Sui, Y., Saab, R., Almeida, C. B. D., Raghav, K. P. S. (2025). Telisotuzumab adizutecan (ABBV-400; Temab-A) monotherapy vs trifluridine/tipiracil plus bevacizumab in patients with refractory metastatic colorectal cancer with increased c-Met protein expression: An open-label, randomized, phase 3 trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps3635